American Well Corporation Morgan Stanley 24th Annual Global Healthcare Conference
Review the key takeaways and the transcript of this earnings call.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
All right, great. Well, welcome. Last day of the conference, we will bring it on home, Mark. So appreciate you being here. We are pleased to have with us COO Mark Hirschhorn. So welcome. Thank you, Chris.
Before we get started, I do have to read for important disclosures. You can find them on the Morgan Stanley website, www.morganstanley.com/researchdisclosures. With that, Mark, I wanted to start on the government side of your business just because I feel like that is the important pivot in terms of where you are seeing a lot of activity and momentum. Perhaps just take us back to the initial DHA, what was required to get to where you are today, and we can build off of that.
Well, I appreciate the opportunity, and thanks again for having me here. The military and the opportunity underscoring where we have pivoted over the past two years to principally focus on the government opportunities as well as domestic payers came about as a result of a probably five-year-old relationship now with the DHA. When they came to us seeking a platform that can enable all of their clinicians to reach any of the service men and women and their families with video compliant and security protocols that had not previously existed, it was a fresh build for us. It was an undertaking that we believed we can accomplish in a period of approximately a year and a half. Along the way, we got to understand and to know the individuals who were involved in that decision-making.
Clearly, many people in those government positions have changed, but their focus on enabling care and moving towards an innovative technological solution for all of their services, underscoring the need for the compliance with the MHS GENESIS Oracle-based platform, was something that held true throughout. Our first really dipping the toe into that experience was launching with the DHA and covering now approximately 10 million service members. We also were invited in from an opportunity that the VA, I think very timely, of course, after we've now had two years of successful service past our initial implementation point.
The VA came to us with a very similar need, and I think the validation from their colleagues down the hall led to us having an opportunity to present, to validate some of the ROI, and the ability to launch and to rely on a platform that is going to service, yet again, another cohort of approximately 10 million veterans.
That's great, and I do want to build on that. You've also early on partnered with Leidos, so I'm just curious, given their experience in this market, are there things you learn from working with a company like that and how you see this market as you go forward in terms of relationships like that versus now you're direct and have exposure with these government agencies?
Well, we're certainly looking forward to being direct, but at the same time, it's somewhat of a bittersweet change. Leidos and some of the other partners were absolutely wonderful. They essentially held our hand throughout this process and guided us towards successful implementation and launch. Their project managers have tremendous experience. The tenure of many of the individuals on their team really helped lead us to a successful launch. I don't believe we would be able to have done that in the timeframe that we did. We would have had the normal growing pains and stumbled, and I think we were very fortunate to have had them leading us through this process.
Now that we're going direct, we're going through some of the initial challenges, going through contracting and pricing and working on a number of things that we had hoped would have been completed about a month or 2 ago. But we're now getting to know people and form relationships. Also, the fact that there are people involved who weren't there at the initial launch. So it takes time. Relationship-building is going on. The contracting is coming into place. And we hope to be in a place where we can announce a longer-term direct contract over the next several weeks.
Got it. To that point, you had announced on the earnings call that letter of intent. And I'm just curious how competitive that process was. It doesn't have to be specific, but just give us a sense in terms of what really appealed for them in terms of getting a sole source and providing you with that opportunity.
Well, so the letter of intent is specifically to the VA. So that's one opportunity that I can tell you the VA had been looking at options for the past 2 years. They went through a diligence process of at least a year and then announced to us this year their intent to move forward with us. Also, changes in the VA that have now led to them having to go back and essentially review and appoint new individuals to now lead in the contracting process, which they've made it clear to us they would like to have completed prior to the year-end.
Got it. Anything on the competitive nature of this in terms of as they kind of evaluated you and potentially others out there in the- Well, we certainly know there were competitors because we're constantly being critiqued, or I should say, criticized in scope, in optionality around the Amwell Platform, as well as pricing.
It's still in a very meaningful way being addressed at basic contract levels today. We're not close to signing in the next several weeks, but we hope to be there in the next couple of months.
Got you. You mentioned before having kind of their friends down the hall helps.
Yes It's a great proof point.
There's that. Anything else you would point to in terms of your capabilities where you feel like you kind of came out on top in this process?
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.
View the full transcript with ProCall participants
2 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
